Advanced Asset Management Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.2K Hold
180
0.01% 73
2026
Q1
$30.4K Hold
180
0.01% 67
2025
Q4
$30.4K Hold
180
0.01% 71
2025
Q3
$26K Hold
180
0.01% 75
2025
Q2
$22.8K Hold
180
0.01% 76
2025
Q1
$23K Hold
180
0.01% 76
2024
Q4
$23.8K Hold
180
0.01% 78
2024
Q3
$24.7K Hold
180
0.01% 80
2024
Q2
$24.7K Hold
180
0.01% 81
2024
Q1
$24.7K Hold
180
0.01% 84
2023
Q4
$24.5K Sell
180
-60
-25% -$7.32K 0.01% 85
2023
Q3
$29.4K Hold
240
0.01% 84
2023
Q2
$30.5K Hold
240
0.01% 81
2023
Q1
$31K Hold
240
0.01% 81
2022
Q4
$31.5K Hold
240
0.01% 118
2022
Q3
$28K Hold
240
0.01% 79
2022
Q2
$28K Hold
240
0.01% 79
2022
Q1
$31K Hold
240
0.01% 77
2021
Q4
$37K Hold
240
0.01% 81
2021
Q3
$39K Hold
240
0.01% 85
2021
Q2
$39K Sell
240
-60
-20% -$9.24K 0.01% 84
2021
Q1
$45K Hold
300
0.01% 87
2020
Q4
$45K Hold
300
0.01% 86
2020
Q3
$41K Hold
300
0.01% 85
2020
Q2
$41K Hold
300
0.01% 82
2020
Q1
$32K Hold
300
0.01% 103
2019
Q4
$36K Buy
+300
New +$33.5K 0.01% 106

Other funds holding IBB

Advanced Asset Management Advisors's IBB Position: Q2 2026 in Review

Advanced Asset Management Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 180 shares worth $34.2K. The position accounts for 0.01% of the portfolio, ranked #73.

Advanced Asset Management Advisors first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $45K in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Advanced Asset Management Advisors held 180 shares of iShares Biotechnology ETF worth $34.2K as of Q2 2026.
  • Advanced Asset Management Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Advanced Asset Management Advisors's portfolio in Q2 2026, its #73 holding.
  • Advanced Asset Management Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • Advanced Asset Management Advisors's iShares Biotechnology ETF position peaked at $45K in Q1 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Advanced Asset Management Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.